Beta Pharmaceuticals Held C14 Marked New Crown Innovative Drug Technology Summary Meeting
Release time:
2022-06-06
On the afternoon of April 29, Dr. Li Gang, Chairman of Wuxi Beta Pharmaceutical Technology Co. The company's chief executive officer (CEO) Zhu Chenggu, chief technology officer (CTO) Cai Dinglong, project leader Yan Shengwang, and relevant personnel from the R & D center, comprehensive administration department, and marketing department attended the meeting.

At the meeting, Chairman Li Gang expounded the importance of the project, first of all, fully affirmed the experience and achievements gained in tackling key problems, and praised all the personnel involved in the project. He said that since the outbreak of the new crown epidemic, the company has been looking for opportunities to contribute to China's fight against the epidemic, this project we must overcome all difficulties, complete the marking work as soon as possible, for the early three clinical follow-up research work to buy time.
The participants discussed, combed and summarized and analyzed the early stage of the project.CTO Cai Dinglong focused on the research and development process of key intermediates that must be used in the project. Zhu Zenggu, CEO of the company, put forward the following requirements for the follow-up marking and synthesis of the project: first, we should improve the technical research organization and clarify the responsibilities and objectives; second, we should develop ideas for tackling key technical problems and improve the accuracy of operation; third, we should strengthen the internal communication of R & D personnel and fully release the innovation vitality of talents; fourth, we should strengthen our confidence and go all out to carry out R & D work to ensure the project ahead ahead of schedule and assist customers. While recognizing the arduousness and difficulty of the project, we should also see the prospect of the project and carry out technical research with a positive and optimistic attitude. This has a good effect on the development of our daily research and development work, and can also promote the company's technological innovation to a new level.
Related News